New TyG-ABSI Index Outperforms Traditional Markers for Heart Disease Risk
Large NHANES study shows TyG-ABSI index better predicts cardiovascular disease and death in metabolic syndrome patients than standard measures.
Summary
Researchers analyzed 12,813 Americans with metabolic syndrome and found that a new composite index called TyG-ABSI outperformed traditional risk markers in predicting cardiovascular disease and death. TyG-ABSI combines insulin resistance (TyG index) with central obesity (ABSI) into a single measure. Each 1-unit increase in TyG-ABSI was associated with 28% higher cardiovascular disease risk, 25% higher cardiovascular death risk, and 28% higher all-cause death risk. The index showed superior predictive performance compared to BMI-based measures, suggesting it could improve risk assessment in metabolic syndrome patients.
Detailed Summary
A comprehensive analysis of 12,813 Americans with metabolic syndrome has revealed that a novel composite index called TyG-ABSI significantly outperforms traditional risk markers in predicting cardiovascular disease and mortality. The study, published in Cardiovascular Diabetology, used data from the National Health and Nutrition Examination Survey (NHANES) spanning 2001-2018.
TyG-ABSI combines the triglyceride-glucose (TyG) index, which measures insulin resistance, with the A Body Shape Index (ABSI), which captures central obesity patterns independent of overall body size. This integration addresses a key limitation of existing markers that typically focus on single metabolic aspects rather than the complex interplay between insulin resistance and abdominal fat distribution.
The results were striking: for each 1-unit increase in TyG-ABSI, participants faced a 28% increased risk of cardiovascular disease (HR 1.28, 95% CI 1.19-1.38), 25% higher risk of cardiovascular death (HR 1.25, 95% CI 1.09-1.43), and 28% elevated risk of all-cause mortality (HR 1.28, 95% CI 1.19-1.38). These associations showed clear dose-response relationships across tertiles, with the highest tertile showing the strongest associations.
When compared head-to-head with other TyG-derived indices like TyG-BMI, TyG-WC, and TyG-WHtR, TyG-ABSI demonstrated superior predictive performance across multiple statistical measures including ROC curves, net reclassification improvement (NRI), and decision curve analysis (DCA). The index maintained its predictive value even after extensive adjustment for demographic, lifestyle, and clinical factors.
For clinicians and health-conscious individuals, TyG-ABSI offers a practical advantage: it can be calculated using readily available measurements (triglycerides, glucose, waist circumference, height, and BMI) without requiring expensive imaging or specialized tests. This makes it particularly valuable for routine screening and risk stratification in primary care settings. The study's use of nationally representative data and robust statistical methods, including competing risk models and sensitivity analyses, strengthens confidence in these findings for the broader metabolic syndrome population.
Key Findings
- Each 1-unit increase in TyG-ABSI associated with 28% higher cardiovascular disease risk (HR 1.28, 95% CI 1.19-1.38)
- TyG-ABSI linked to 25% increased cardiovascular mortality risk (HR 1.25, 95% CI 1.09-1.43)
- All-cause mortality risk increased 28% per unit TyG-ABSI increase (HR 1.28, 95% CI 1.19-1.38)
- Clear dose-response relationship observed across TyG-ABSI tertiles for all outcomes
- TyG-ABSI outperformed TyG-BMI, TyG-WC, and TyG-WHtR in ROC curve analysis and predictive metrics
- Associations remained significant after adjustment for 20+ demographic, lifestyle, and clinical variables
- Study included 12,813 metabolic syndrome patients from nationally representative NHANES data (2001-2018)
Methodology
This cross-sectional and prospective cohort study analyzed 12,813 adults with metabolic syndrome from NHANES 2001-2018. Researchers used complex survey-weighted Cox proportional hazards models for mortality outcomes and logistic regression for cardiovascular disease prevalence. Follow-up extended through December 2019 via linkage to the National Death Index. Multiple statistical approaches including competing risk models, restricted cubic splines, and sensitivity analyses validated the findings.
Study Limitations
The study's observational design cannot establish causality between TyG-ABSI and outcomes. Self-reported cardiovascular disease diagnoses may introduce recall bias. The analysis was limited to U.S. populations, potentially limiting generalizability to other ethnic groups or healthcare systems. Authors did not report significant conflicts of interest.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.